中文 | English
Return
Total: 211 , 1/22
Show Home Prev Next End page: GO
Author:( Xiujuan ZHANG)

1.Expert recommendations on vision friendly built environments for myopia prevention and control in children and adolescents

PAN Chenwei, LI Danlin, HE Xiangui, LI Shiming, LIU Lei, ZHANG Xiujuan, GUO Yin, LIU Hu, HU Ke, WAN Wenjuan, ZHANG Xiaofeng, LUO Chunyan, YANG Jie, XU Hua, TAO Fangbiao

Chinese Journal of School Health 2026;47(1):1-5

2.Synthesis and anti-inflammatory activity of three series of coumarin-based derivatives

Xiujuan ZHAO ; Hengli YANG ; Jinye WU ; Xiaoqi ZHENG ; Yaoping ZHANG ; Yuping LIN ; Chunyan HU

Journal of China Pharmaceutical University 2025;56(1):40-48

3.Analysis of classroom environment hygiene in primary and secondary schools in Guizhou Province from 2022 to 2024

HUANG Xiaoli, ZHANG Xiaoqin, LI Xin, PENG Xiying, WANG Zhuan, LU Xiujuan

Chinese Journal of School Health 2025;46(7):1032-1036

4.Epidemiological characteristics of spinal curvature abnormalities in children and adolescents

LU Xiujuan, LI Xin, PENG Xiying, WANG Zhuan, HUANG Xiaoli, ZHANG Xiaoqin

Chinese Journal of School Health 2025;46(7):1046-1050

5.Role of artificial intelligence in medical image analysis.

Lu WANG ; Shimin ZHANG ; Nan XU ; Qianqian HE ; Yuming ZHU ; Zhihui CHANG ; Yanan WU ; Huihan WANG ; Shouliang QI ; Lina ZHANG ; Yu SHI ; Xiujuan QU ; Xin ZHOU ; Jiangdian SONG

Chinese Medical Journal 2025;138(22):2879-2894

6.Premature mortality projection for diabetes to 2030: a subnational evaluation towards the Healthy China 2030 Goals.

Hongrui ZHAO ; Zhenping ZHAO ; Xuan YANG ; Yuchang ZHOU ; Ainan JIA ; Jiangmei LIU ; Peng YIN ; Yamin BAI ; Zhenxing YANG ; Maigeng ZHOU ; Xiujuan ZHANG

Frontiers of Medicine 2025;19(4):626-635

7.Cost effectiveness analysis between osimertinib and gefitinib in the treatment of advanced non-small cell lung cancer with epidermal growth factor receptor mutation

Na LI ; Chengwen HUANG ; Xiujuan SUN ; Xiaohong WANG ; Li ZHANG ; Xingpo WANG

Journal of Pharmaceutical Practice and Service 2025;43(12):619-624

8.Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial

Yan ZHAO ; Jianzhong ZHANG ; Bin YANG ; Jingyi LI ; Yangfeng DING ; Liming WU ; Litao ZHANG ; Jinyan WANG ; Xiaohong ZHU ; Furen ZHANG ; Xiaohua TAO ; Yumei LI ; Chunlei ZHANG ; Linfeng LI ; Jianyun LU ; Qingchun DIAO ; Qianjin LU ; Xiaoyong MAN ; Fuqiu LI ; Xiujuan XIA ; Hao CHENG ; Yingmin JIA ; Guoqing ZHAO ; Jinchun YAN ; Bo CHEN

Chinese Medical Journal 2024;137(2):200-208

9.A study on the association between exposure of uric acid accumulation and risks of acute pancreatitis

A'fang SU ; Guangjian LI ; Yunshui ZHANG ; Xiujuan ZHAO ; Shouling WU ; Xiaozhong JIANG

The Journal of Practical Medicine 2024;40(14):2009-2014

10.Establishment and verification of reference intervals for blood cell ratios in apparently healthy people

Jingzhu NAN ; Xu ZHANG ; Hui YUAN ; Xuemei WEI ; Shuai ZHANG ; Chen WANG ; Xiujuan LI ; Honghao LU ; Xiaoran SHEN

International Journal of Laboratory Medicine 2024;45(19):2396-2402,2407

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 211 , 1/22 Show Home Prev Next End page: GO